1. Like a specialized Corteva or Syngenta, focusing on climate-resilient crop technologies.
2. The 'Tesla' of sustainable agriculture, developing crops that can withstand drought and salinity.
3. A 'Bayer for crops' focused on developing drought and salinity tolerant seeds.

• HB4 Drought and Salinity Tolerance Technology: A proprietary genetic technology enabling crops like soybeans and wheat to better withstand drought and high-salinity conditions.
• HB4 Soybeans: Genetically engineered soybean seeds incorporating the HB4 technology for enhanced drought and salinity tolerance.
• HB4 Wheat: Genetically engineered wheat seeds incorporating the HB4 technology for enhanced drought and salinity tolerance.
• Seed Inoculants: Biological products containing beneficial microorganisms that enhance nutrient uptake and promote plant growth, particularly for legumes.
• Biofertilizers: Biological formulations designed to improve soil fertility and nutrient availability for plants, often through microbial activity.
• Biopesticides and Biofungicides: Biological products developed to control agricultural pests and plant diseases, providing sustainable alternatives to chemical treatments.
• Adjuvants and Specialty Products: Formulations designed to enhance the efficacy of crop protection products and improve nutrient delivery.

Federico Trucco, Chief Executive Officer, Executive Director

Federico Trucco is a biochemist with a Ph.D. in Crop Sciences from the University of Illinois at Urbana-Champaign. He joined Bioceres in 2005 as a research leader and helped develop and run Bioceres' biotech center INDEAR. He became the first formal CEO of Bioceres in 2011 and has been the CEO of Bioceres Crop Solutions (BIOX) since March 2019. His father, Víctor Trucco, was a co-founder of Bioceres. Trucco has also served as chairman of the Argentine Chamber of Biotechnology.

Scott Crocco, Interim Chief Financial Officer, Non-Executive Director

Scott Crocco is a seasoned executive with over three decades of experience in finance and operations across both public and private companies. He assumed the role of interim CFO for Bioceres Crop Solutions effective August 20, 2025, following the departure of Enrique Lopez Lecube. Previously, Mr. Crocco served as CFO of Air Products & Chemicals, Inc. (NYSE: APD), where he led corporate restructuring and portfolio transformation. He also held the position of Chief Financial Officer at Imperial Dade, a company backed by private equity.

Jorge Wagner, Chief Operating Officer, Head Global Manufacturing And Supply

Jorge Wagner has served as the Chief Operating Officer of Bioceres Crop Solutions since October 2016. He also held the role of Chief Financial Officer at Rizobacter, a Bioceres subsidiary, starting in 2013. Prior to his time at Bioceres, he was the regional Chief Financial Officer for Syngenta Agro S.A. for Paraguay, Uruguay, Argentina, and Bolivia from 2010 to 2013.

Gerónimo Watson, Chief Technology Officer

Gerónimo Watson holds the position of Chief Technology Officer at Bioceres Crop Solutions.

Ricardo Yapur, Managing Director of Rizobacter Argentina S.A.

Ricardo Yapur serves as the Managing Director of Rizobacter Argentina S.A., a key subsidiary of Bioceres Crop Solutions.

Bioceres Crop Solutions (BIOX) operates in several key agricultural markets. The addressable markets for its main products and services are sized globally unless otherwise specified:

• Seed Technologies (including HB4 Drought-Tolerant Seeds):
  • The global commercial seeds market was valued at approximately USD 85.42 billion in 2024 and is projected to reach USD 138.32 billion by 2030, growing at a CAGR of 8.4%. Other estimates for the global seed market size in 2024 range from USD 61.68 billion to USD 88.82 billion, with projections up to USD 128.26 billion by 2032.
  • The global drought-tolerant seeds market, where Bioceres' HB4 technology is positioned, was valued at approximately USD 7.63 billion in 2024 and is expected to reach USD 12.34 billion by 2032, with a CAGR of 6.20%. Another source estimates this market at USD 8.89 billion in 2024, projected to reach USD 16.33 billion by 2032 at a CAGR of 7.9%.
  • The global soybean seed market was estimated at USD 10.62 billion in 2024 and is anticipated to increase from USD 11.37 billion in 2025 to USD 21.09 billion by 2034, growing at a CAGR of 7.1%.
  • The global wheat seed market size was estimated at USD 4.5 billion in 2023 and is projected to reach approximately USD 6.9 billion by 2032, with a compound annual growth rate (CAGR) of 4.8%. Other estimates for the global wheat seed market in 2024 range from USD 5.5 billion to USD 5.52 billion, with projections up to USD 7.36 billion by 2033.
• Crop Protection Solutions (including Biopesticides):
  • The global crop protection chemicals market was estimated at USD 47.78 billion in 2024 and is projected to reach USD 66.74 billion by 2030, growing at a CAGR of 5.8%. Other estimates for the global crop protection chemicals market in 2024 range from USD 75.24 billion to USD 87.15 billion, with projections up to USD 118.12 billion by 2032.
  • The global biopesticides market was valued at USD 3.5 billion in 2024, with expectations to reach USD 8.7 billion by 2034, growing at a CAGR of 9.3%. Other estimations for the global biopesticides market in 2024 range from USD 2.71 billion to USD 8.0 billion, with projections up to USD 21.5 billion by 2033.
• Crop Nutrition Solutions (including Biofertilizers and Biostimulants):
  • The global crop nutrition market was valued at US$ 5.7851 billion in 2023 and is projected to reach US$ 10.3066 billion by 2030, at a CAGR of 8.6%.
  • The global biofertilizers market was estimated at USD 1.38 billion in 2024 and is projected to reach USD 2.83 billion by 2030, growing at a CAGR of 12.8%. Other estimates for the global biofertilizers market in 2024 range from USD 2.5 billion to USD 3.4 billion, with projections up to USD 8.8 billion by 2033.
  • The global biostimulants market size was calculated at US$ 3.06 billion in 2024, grew to US$ 3.29 billion in 2025, and is projected to reach around US$ 6.26 billion by 2034, expanding at a CAGR of 7.44%. Other estimates for the global biostimulants market in 2024 range from USD 3.1 billion to USD 4.87 billion, with projections up to USD 12.85 billion by 2034.

1. Increased Adoption and Commercialization of HB4 Drought-Tolerant Technology: Bioceres' HB4 drought-tolerant seed technology is a significant driver, having been instrumental in maintaining double-digit top-line growth in recent quarters and contributing to full-year revenue growth for fiscal 2024. The company possesses key registrations and manufacturing capacity to support its three-year plan for HB4 rollout, and it holds a unique position as the first to achieve drought-tolerant wheat and soy.

2. Strategic Shift to a Capital-Light Business Model and Partnerships: Bioceres is transitioning its seed business by exiting breeding, seed production, and seed commercialization to focus on high-margin trait development and strategic partnerships with leading seed companies. Collaborations, such as those with GDM for soybeans and Florimond Desprez for wheat, are anticipated to generate new revenue streams through trait management and commercialization opportunities.

3. Growth in High-Margin Biological Products: The company is emphasizing its high-margin biologicals business, including bioprotection products and biostimulants. The Crop Protection segment has demonstrated significant gross profit growth driven by bioprotection, and biostimulants have emerged as strong performers, particularly in Europe, offsetting challenges in other categories. International markets have shown resilience with strong sales of bioprotection products and adjuvants.

4. Geographic Diversification and International Market Expansion: Bioceres is pursuing a strategy of geographic diversification and expansion into international markets like Brazil and the U.S. This expansion helps to reduce reliance on the often-volatile Argentinian market and capitalize on new growth opportunities abroad. Growth in biostimulants in Europe has also contributed to this diversification.

5. Recovery in the Argentinian Market: While recent performance has been impacted by macroeconomic pressures, weak demand, and a challenging environment for certain products in Argentina, a recovery in this key domestic market is expected to drive future revenue growth. Analysts anticipate that a stabilization and rebound in Argentina will contribute to the company's upside potential.

Share Repurchases

• As of June 30, 2023, Bioceres Crop Solutions had acquired 667,578 ordinary shares under its Buy-Back Program.
• The Board of Directors approved a program to repurchase up to US$10,000,000 of its securities to enhance capital allocation to equity-finance obligations.

Share Issuance

• Between June 30, 2023, and June 30, 2024, the number of ordinary shares issued and outstanding increased from 62,796,774 to 62,848,483.
• In March 2022, holders of a convertible note with an outstanding principal amount of $49.1 million committed to convert 75% of this principal into Bioceres common stock.

Outbound Investments

• In March 2022, Bioceres Crop Solutions entered into a definitive agreement to acquire Marrone Bio Innovations, Inc. (MBI) in an all-stock transaction.
• This acquisition was valued at approximately $236 million, based on the share prices of Bioceres and MBI at market close on March 15, 2022.
• Upon closing, MBI shareholders were expected to own approximately 16 million shares of Bioceres.

Capital Expenditures

• For the fiscal year ended June 30, 2025, capital expenditures amounted to $18.4 million.
• The average annual capital expenditures growth rates for Bioceres Crop Solutions Corp have been -27% over the past three years and -33% over the past five years.